MDL 2741 · U.S. District Court, Northern District of California
If you used Roundup and were told you have non-Hodgkin lymphoma, ask a lawyer about your options. Keep your diagnosis and use records for review.
Updated 15 sources
See If You Qualify
Free · No obligation · About 2 minutes
Updated 15 sources
This may apply to you if
The process
You answer a few questions
About two minutes. Nothing is sent until you agree on the last step and press submit.
A lawyer looks at it
A lawyer at the firm reads your answers and checks them against the current case criteria.
The firm decides and gets in touch
If the firm takes your case, you get the terms in writing to read before you sign. You can always say no.
At a glance
Who qualifies
These are cited sources. Their inclusion does not imply that they endorse People’s Justice or reviewed this page.
International Agency for Research on Cancer · World Health Organization · Cancer agency issuing the March 2015 evaluation
Finding: The agency classified glyphosate as a probable human cancer hazard using limited human evidence and animal evidence.
IARC glyphosate evaluation, March 20, 2015 (opens in a new tab) · Mar 20, 2015 · Checked Oct 3, 2026
National Cancer Institute and Agricultural Health Study collaborators · Journal of the National Cancer Institute · 2018
Read the source: Glyphosate Use and Cancer Incidence in the Agricultural Health Study (opens in a new tab) · Checked Oct 3, 2026
International Agency for Research on Cancer, World Health Organization · 2015
Read the source: IARC Monographs Volume 112 glyphosate evaluation (opens in a new tab) · Checked Oct 3, 2026
Not covered by this case
Ask what share comes from a recovery and what is owed if there is none.
Source: ABA Model Rule 1.5: fees · as of Oct 3, 2026
The fee guide warns that expenses can remain payable without a recovery.
Source: ABA: fees paid from a successful claim · as of Oct 3, 2026
Covered providers may charge reasonable copying costs, but not a record-search fee.
Source: HHS: Your Medical Records · as of Oct 3, 2026
List your providers and ask for existing medical records before sending sensitive files.
Source: HHS: Your Medical Records · as of Oct 3, 2026
Ask how your diagnosis, use history and prior case affect the court or program route.
Source: Court-authorized Weed Killer Class notice and FAQs · as of Oct 3, 2026
Read the fee and expense agreement before hiring a firm. Keep a copy of what you sign.
Source: ABA Model Rule 1.5: fees · as of Oct 3, 2026
41% increased risk of NHL among highest-exposed individuals (OR = 1.41, 95% CI: 1.13-1.75)
Classified glyphosate as Group 2A — "probably carcinogenic to humans"
No statistically significant overall association between glyphosate and NHL in the full cohort
If you used Roundup and have non-Hodgkin lymphoma, ask a lawyer to review your options. A proposed class deal has detailed rules about exposure, diagnoses and earlier cases. Having used the product does not itself promise a payment. [7]
Begin with the exact name of the cancer in your medical record. The class notice concerns non-Hodgkin lymphoma and specified related diagnoses, not every cancer. Ask your care team to explain the diagnosis; this guide cannot identify a disease from symptoms. Bring the product name and any label or old receipt you still have. Do not guess that every weed killer contained the same ingredient. [7]
Describe where and when you mixed, sprayed or worked near the product. Note home use separately from farm or paid work. The notice treats work and home exposure differently, and an earlier federal case can affect class membership. Tell the lawyer about any claim, signed release or court decision. Have them check the full rules before deciding whether a program covers you. [7]
Roundup claims now need review in light of a June 25, 2026 Supreme Court ruling. The Court barred a state-law warning claim that would require a cancer warning different from the federal label. That holding does not decide every possible claim or your personal options. [1]
Separately, a Missouri court gave a proposed class deal initial approval on March 4, 2026. An August 6 order moved its fairness hearing to September 14. The administrator says that hearing took place and the court will decide approval. We have not verified a later final court order. Ask for the latest entered order, rather than relying on an old news headline. [5] [6] [7]
The federal case and the proposed class program are not the same route. The class notice has special rules for people with a federal case pending on its specified date. Do not dismiss an existing case or sign away rights based on this guide. Have your own lawyer explain how the Supreme Court ruling and class terms affect the claims you actually have. [7] [1]
No one has announced a guaranteed payment to you in the class notice reviewed here. The notice gives proposed payment categories and rules, rather than a personal offer. Approval, eligibility, proof and deductions still matter. [7]
The program describes different treatment of work and home exposure, age at diagnosis and cancer type. It also describes how proof and treatment can change a score. This guide does not turn those categories into a payout estimate. Ask the lawyer to show you the applicable official terms and explain what is still conditional. A headline about a fund is not the amount a family would take home. [7]
Keep bills, treatment records and lost-work notes for the discussion. Ask about the agreed private fee, expenses and any health-bill repayment claim. The notice separates program funds, lawyer fees and medical repayment issues. We have not calculated a net payment, tax result or arrival date for anyone. Keep any actual offer for a lawyer to review before accepting it. [7] [10]
Ask whether you are seeking program information or hiring your own Roundup lawyer. The class notice distinguishes class lawyers from private lawyers. If you hire privately, read the fee and expense terms before agreeing. [7] [12]
Ask the firm to explain the share it would keep if money is recovered. Ask who pays case costs if there is no recovery. The ABA fee guide warns that expenses and a success-based legal fee are different. Its model rule calls for written terms covering the method and deductions. Those sources do not verify this website’s partner price, free check or availability. [10] [12]
For records, ask the hospital what copies are needed and what copying costs may apply. HHS gives patients access rights at covered providers, with exceptions. It permits reasonable copying and mailing charges, but not a record-search fee. Do not pay a third party for a full records package before asking the lawyer what would be useful. [8]
A lawsuit deadline and a class-program choice can be different dates. The class notice lists June 4, 2026 for opting out or objecting. That program date does not establish that every person has no legal option now. [7] [11]
Ask a lawyer to review your exposure dates, diagnosis, state and any previous agreement or court action. Bring the notice or letter itself if you received one. Do not assume a deadline starts on the day you saw an ad. Ask which rule applies, what event starts it and whether any exception matters. Your own records should guide that discussion, not a guessed date.
The notice ties some registration and claim steps to final approval and resolution of appeals. Those are different triggers, and the correct calendar date needs checking. Our review has not verified a final entered order, so we do not invent a deadline from a hearing date. Have the lawyer or administrator identify the current official instruction for your situation. [7]
Start with the diagnosis record and a short account of product use. Ask your medical team about symptoms and treatment, rather than using a claim page to diagnose cancer. Then ask a lawyer to review the legal route and program status. [7]
For each location, note the tasks you did, the years involved and how often you handled the product. Keep existing labels, purchase records or work documents. If another person recalls the same work, write down their name and what you want to ask them. Mark uncertain dates as uncertain. Do not handle old chemicals or repeat exposure to collect new evidence.
If a relative is helping, decide with the patient what help they want. Ask the provider and lawyer which permissions are needed before requesting or sending records. HHS limits medical-record access to the patient or proper personal representative. A family connection does not automatically give someone that authority. We have not verified this intake’s privacy, recipients or contact terms. [8]
A website check does not file a Roundup case or enroll you in the class program. Court filings and program claims have their own steps. Ask the receiving firm which route it is reviewing and what you would need to sign. [9] [7]
First, identify who receives your answers and whether they are taking cases like yours. Next, ask them to review the diagnosis, exposure and earlier legal history. Then read the fee and data terms before hiring or sending sensitive files. No contact time, case acceptance, secure intake promise or representation guarantee is certified by this draft.
If you already have a lawyer, bring any class notice to that lawyer first. The notice explains that some people with existing federal cases are treated differently. A program choice may affect legal rights. Ask for an explanation of what you keep or give up, and keep copies of the answer and any form. This guide does not advise you to join, opt out or dismiss a claim. [7]
The scientific record contains different findings about glyphosate and cancer. IARC classified it as a probable cancer hazard in 2015, using limited human evidence and animal evidence. A large later cohort did not find an overall link with non-Hodgkin lymphoma. [2] [3]
The cohort followed licensed pesticide users in Iowa and North Carolina. Exposure came from people’s reports, while cancer diagnoses came from registries. Its result describes that study population, not every product or setting. The IARC review explains that other causes of an observed link could not be ruled out. Neither source proves what caused one person’s cancer. [3] [2]
EPA’s current page says its assessment differs from IARC and an updated human-health review is expected in late 2026. An expected review is not a finished finding. The evidence box names the source, design and limits so readers can see the difference. Court decisions about labels and legal duties are separate from a medical diagnosis or research result. [4] [1]
These questions focus on Roundup use, the proposed class program and existing claims. Answers separate medical findings from court rules and personal legal advice. Review the full notice and your own records before making a program choice.
The sources below include the Supreme Court opinion, signed Missouri orders, current administrator notice and primary health research. They were read for this draft on October 3, 2026. Some administrator text still describes Supreme Court review as pending; the June 2026 opinion controls that point. No cited source is presented as endorsing this website. [7] [1]
People bringing these claims allege that glyphosate, Roundup’s active ingredient, can damage cells through oxidative stress and DNA damage, and that this can lead to non-Hodgkin lymphoma. Monsanto denies that Roundup causes cancer, and IARC and the U.S. EPA have reached different conclusions about glyphosate. The points below describe the proposed mechanisms, not a finding about any one person’s cancer.
Glyphosate generates reactive oxygen species (free radicals) that cause breaks in DNA strands. When DNA repair mechanisms cannot keep up, mutations accumulate in genes that control cell growth — the first step toward cancer.
Studies of agricultural workers exposed to glyphosate show elevated rates of chromosomal damage, including micronuclei and sister chromatid exchanges — biomarkers that indicate increased cancer risk.
Claimants point to the IARC classification, epidemiology studies, internal company documents and earlier jury verdicts. Monsanto denies that Roundup causes cancer, and none of these points decides your own case. A lawyer can review your exposure history and medical records.
Non-Hodgkin lymphoma is a group of blood cancers that develop in the lymphatic system — the network of tissues and organs that help fight infection. NHL begins when lymphocytes (a type of white blood cell) grow abnormally and accumulate, forming tumors in lymph nodes, the spleen, bone marrow, or other organs. Unlike Hodgkin lymphoma, which follows a predictable pattern of spread, NHL can develop in many different parts of the body.
Swelling in the neck, armpit, or groin that doesn’t go away. Often the first noticeable sign.
Losing 10% or more of body weight over 6 months without trying.
Extreme tiredness that doesn’t improve with rest.
Drenching sweats during sleep, severe enough to soak bedsheets.
Recurring fevers above 100.4°F with no apparent cause.
Can indicate lymphoma in the spleen or abdominal lymph nodes.
The prognosis for non-Hodgkin lymphoma depends heavily on the specific subtype, stage at diagnosis, and the patient’s overall health. Indolent subtypes like follicular lymphoma often respond well to treatment and have high long-term survival rates. Aggressive subtypes like DLBCL require prompt treatment but can often be cured with R-CHOP chemotherapy. Advances in immunotherapy, particularly CAR-T cell therapy, have improved outcomes for patients who don’t respond to initial treatment.
Your risk of developing cancer from Roundup depends on how much glyphosate you were exposed to and for how long. Three main groups face elevated risk.
Occupational
Occupational
Consumer
There is no proven safe level of glyphosate exposure. Even light residential use over multiple years may increase cancer risk. This assessment is for informational purposes — an attorney can evaluate the strength of your specific case.
The Roundup litigation has triggered significant investor backlash against Bayer management, with multiple shareholder lawsuits alleging the board failed in its due diligence before acquiring Monsanto.
Downgraded from A3 to Baa1 (2020-2023)
Cited Roundup litigation as key risk factor
Downgraded from A- to BBB+ (2022)
Litigation reserves and settlement costs weighed on creditworthiness
Bayer has paid more in Roundup settlements than most companies are worth.
Regulatory agencies worldwide have taken conflicting positions on glyphosate safety, creating a complex landscape. The divergence between the IARC’s cancer classification and the EPA’s "not likely carcinogenic" finding is central to the litigation.
The World Health Organization’s cancer research agency classified glyphosate as probably carcinogenic in 2015. While the EPA has taken a different position, internal documents show Monsanto influenced that assessment. Three consecutive juries found the evidence of cancer causation persuasive.
Every state has a statute of limitations — a legal deadline — for filing a Roundup lawsuit. Whether that time has passed depends on your facts, so don't rule yourself out. A lawyer can tell you. Most states apply a "discovery rule" that starts the clock when you learned (or should have learned) that Roundup may have caused your cancer.
For most Roundup cases, the statute of limitations does not start when you were first exposed to Roundup or even when you were diagnosed with cancer. Instead, it starts when you discovered — or reasonably should have discovered — that Roundup may have caused your cancer. For many people, this was after the IARC classification in 2015 or after the Johnson verdict in 2018 brought widespread media attention to the cancer link.
In most states, the statute of limitations starts in 2024 when the farmer first connected Roundup to their cancer, not in 2020 when they were diagnosed.
The discovery rule means the deadline starts from the 2023 diagnosis date (when the harm became known), not from when exposure began. In a state with a 2-year SOL, they would have until 2025 to file.
Courts may consider when a reasonable person would have connected Roundup to their cancer. Given the extensive media coverage since 2018, a court might find the clock started earlier than 2025. An attorney can explain how the deadline applies.
If you used Roundup and have been diagnosed with non-Hodgkin lymphoma or another cancer, a lawyer can check your filing deadline. Whether that time has passed depends on your facts, so don't rule yourself out. A lawyer can tell you.
This table provides general guidance. Actual deadlines depend on your specific circumstances, including when you discovered the connection between Roundup and your cancer. An attorney can determine your exact deadline.
Your state
Deadlines vary by state and by case. A lawyer can confirm yours.
Roundup lawsuits can allege that Roundup exposure caused non-Hodgkin lymphoma. In Durnell, the Supreme Court described a user’s failure-to-warn claim alleging that Roundup caused his non-Hodgkin lymphoma, then held the claim was preempted by FIFRA. That opinion does not prove your own cancer’s cause.
Source: Supreme Court: Monsanto v. Durnell, June 25, 2026 · as of Oct 7, 2026
Ask a lawyer to assess the product, exposure, diagnosis, and legal history. The Supreme Court described a claim by a user who alleged about 20 years of Roundup use and non-Hodgkin lymphoma, but it resolved a federal preemption issue. That decision does not decide who has a usable claim.
Source: Supreme Court: Monsanto v. Durnell, June 25, 2026 · as of Oct 7, 2026
No, a notice date is not automatically your filing deadline. Court deadlines and state filing limits depend on the claim and law that applies. A lawyer can check your state deadline and any opt-out or release issue.
Source: SDNY: filing time limits · as of Oct 7, 2026
Ask for written fee and expense terms from the firm you would hire. The class notice distinguishes private lawyers from class lawyers. Costs can be separate from a share-of-recovery fee.
Source: ABA Model Rule 1.5: fees · as of Oct 7, 2026
No. A lawsuit can request money for harm, but that request is not a personal award. The Supreme Court reversed and remanded Durnell on a federal preemption issue, so the opinion does not set a payment for every Roundup claimant.
Source: Supreme Court: Monsanto v. Durnell, June 25, 2026 · as of Oct 7, 2026
It depends. Ask the firm in writing what it charges, what expenses are separate, and what happens if the case does not succeed. Keep the written terms before signing.
Source: ABA Model Rule 1.5: fees · as of Oct 7, 2026
People bringing these claims may allege Roundup needed a cancer warning. The Supreme Court opinion addresses a failure-to-warn claim and federal pesticide-label requirements. It is not a finding that proves every factual allegation in every case.
Source: Supreme Court: Monsanto v. Durnell, June 25, 2026 · as of Oct 7, 2026
Gather product photos, purchase records, use dates, job or yard history, protective-equipment details, and lymphoma diagnosis records. The class notice and court papers do not replace your own proof. A lawyer can check exposure, diagnosis, and prior releases.
Source: HHS: Your Medical Records · as of Oct 7, 2026
Checked against 12 primary sources by People's Justice editors · Updated
How we make moneyThe review is free and private. Asking for it doesn’t commit you to anything.
Register your interest